Impact of Neuropathy on the Risk of Semaglutide-Induced Gastric Retention
NCT07156591 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 460
Last updated 2025-09-05
Summary
A prospective, single-center, observational study to compare the risk of gastric retention between the exposure group (with neuropathy) and non-exposure group (without neuropathy) in diabetic patients receiving uninterrupted semaglutide therapy
Conditions
- Gastric Retention
Interventions
- PROCEDURE
-
Esophagogastroduodenoscopy
Assess the gastric retention during esophagogastroduodenoscopy
Sponsors & Collaborators
-
Fudan University
lead OTHER
Principal Investigators
-
Danian Ji, M.D. · Huadong Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-15
- Primary Completion
- 2028-09-15
- Completion
- 2028-09-15
Countries
- China
Study Locations
More Related Trials
-
A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects
NCT03288740 ·Status: COMPLETED ·Phase: PHASE1
-
Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
NCT02249871 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Food on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
NCT02172313 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study of How the Medicine NNC0480-0389 Taken With Semaglutide Works in the Body of Healthy Chinese Men
NCT05498610 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Long-Acting GLP-1 (Glucagon-like Peptide-1) or Dual Incretin (GLP-1 and GIP [Glucose-dependent Insulinotropic Peptide]) Modulation on Gastric Motor Functions
NCT06801015 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
The Effect of Weekly Semaglutide Treatment on Energy Expenditure
NCT06390501 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants Receiving a Glucagon-like Peptide-1 (GLP-1) Agonist
NCT06500429 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study Investigating How Well Semaglutide Works in People Suffering From Overweight or Obesity
NCT03548987 ·Status: COMPLETED ·Phase: PHASE3
-
Research Study Investigating How Well Semaglutide Works in People With Type 2 Diabetes Suffering From Overweight or Obesity
NCT03552757 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Body Weight Change Through Different Smeglutide Administration Methods
NCT05616052 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Safety of CS0159 Combined With Semaglutide in MASH Patients With Obesity and T2DM
NCT06492330 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Semaglutide Ingection in Subjects With Type 2 Diabetes
NCT05950516 ·Status: UNKNOWN ·Phase: PHASE3
-
A Research Study Looking at How 50 mg Semaglutide Daily Affects Food Intake and Emptying of the Stomach in People With Obesity
NCT05236517 ·Status: COMPLETED ·Phase: PHASE1
-
Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.
NCT04251156 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Effect on Obesity of QW Nimacimab and QW Nimacimab Co-administered With Semaglutide vs Placebo
NCT06577090 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participants
NCT05784402 ·Status: COMPLETED ·Phase: PHASE1
-
Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus
NCT02453711 ·Status: COMPLETED ·Phase: PHASE2
-
"Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."
NCT05249881 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effect of Oral Semaglutide on Epicardial and Pericoronary Adipose Tissues in Type 2 Diabetes After Myocardial Infarction
NCT06557811 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
NCT04822181 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Research Study to See How Well Semaglutide Helps People Who Have a Body Weight Above the Healthy Weight Range
NCT06041217 ·Status: COMPLETED ·Phase: PHASE3
-
STEP 6: Research Study Investigating How Well Semaglutide Works in People Living With Overweight or Obesity
NCT03811574 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Liraglutide in Healthy Japanese Male Volunteers
NCT01515592 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Itopride on Semaglutide Gastroparesis
NCT07254715 ·Status: RECRUITING ·Phase: PHASE4
-
Response to Semaglutide in Non-diabetic Obese Patients With Varying Degrees of Insulin Resistance
NCT06856291 ·Status: RECRUITING